Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biopharma stocks advanced yet again in the week ended Jan. 22, with the change of guard at the White House generating broader market strength. Eli Lilly And ...
10 Best Biotech Stocks to Invest In According To Billionaire Biotech Hedge Fund Joseph Edelman is one of the most successful biotech hedge fund portfolio managers since he founded Perceptive Advisors in 1999, with the strategy of generating gains by investing in small and mid-cap biotechnology stocks. The assets under management of Edelman’s hedge fund soared from $6 million in 1999 to almost $6.85 billion in the last two decades. Its flagship fund, Perceptive Life Sciences Fund, specializes in investing money in small- and mid-cap biotech companies. The fund reported losses in 2002, 2008...
Press release content from PR Newswire. The AP news staff was not involved in its creation. ImmunoPrecise Collaboration Enables Preclinical Manufacturing of Lead Antibodies Targeting SARS-CoV-2 December 11, 2020 GMT VICTORIA, BC, Dec. 11, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV: IPA) (OTCQB: IPATD) (FSE: TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that it has entered into a research collaboration with the National Research Council of Canada’s (NRC) Human Health Therapeutics (HHT) Research C...
/cloudfront-us-east-1.images.arcpublishing.com/tgam/SRF42L5BG5MPBDMDCLXJXGQZGM.jpg)
A Canadian biotech giant is born: AbCellera stock triples in debut, company now worth US$15-billion Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account Getting audio file ... This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer AbCellera/Courtesy of manufacturer AbCellera Biologics Inc. (abcellera) had one of the most explosive debuts of any initial public offering this year as stock of the Vancouver antibody developer – a key player in the fight against COVID-19 – nea...